Test Price
800 AED✅ Home Collection Available
Prothrombin Gene Mutation Analysis (G20210A) in UAE | 800 AED | 2026 DHA Guidelines
تحليل طفرة جين البروثرومبين (G20210A) في الإمارات | 800 درهم | معتمد من هيئة الصحة بدبي
🇦🇪 UAE-Trusted Executive Summary
Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO‑accredited dual‑methodology (Real‑Time PCR + confirmatory WGS), ensuring reliable detection of the G20210A allele associated with hereditary thrombophilia.
Premium Logistics: Paid hospital‑grade home collection via ISO‑certified cold‑chain mobile phlebotomy (8 AM‑11 PM) with chilled EDTA tube handling. No freezing – sample integrity is paramount.
Clinical Guidance: Complimentary telephonic post‑test clinical interpretation by a senior hematologist, aligning with your personal and family thrombotic history.
Insurance: Direct billing verification via WhatsApp at +971 54 548 8731. We handle pre‑approval within minutes.
ملخص تنفيذي: دقة تشخيصية تبلغ 99.9% مع تحليل طفرة جين البروثرومبين (G20210A) عبر تقنيتي Real‑Time PCR والتسلسل الجيني الكامل (WGS) المعتمدتين دولياً. خدمة سحب دم منزلي مدفوعة مع سلسلة تبريد متكاملة، واستشارة طبية هاتفية مجانية لتفسير النتائج. التحقق المباشر من التأمين عبر واتساب. الامتثال الكامل للمرسوم بقانون اتحادي رقم 41 لسنة 2024 (المادة 87) وقانون CDS 2026 للقاصرين وقانون حماية البيانات الشخصية الإماراتي.
Fully compliant with Federal Decree‑Law No. 41 of 2024 (Art. 87), CDS Law 2026 (Minors’ Genetic Testing), and UAE PDPL.
Test Overview: Prothrombin Gene Mutation (Factor II G20210A)
The Prothrombin Gene Mutation Analysis detects the G20210A variant in the F2 gene, a key hereditary risk factor for venous thromboembolism (VTE). This molecular test stratifies lifelong thrombophilia risk, guiding personalised prophylaxis decisions for patients with personal or family clotting history. Published turnaround is 72 hours (Mon–Thu collection); the price is a transparent 800 AED all‑inclusive.
| Feature | Our Test (Prime DHA‑Licensed Lab) | Closest Alternative (Other UAE Lab) |
|---|---|---|
| Precision & Methodology | Real‑Time PCR (qPCR) with confirmatory Whole Genome Sequencing (WGS) – 99.9% sensitivity | Real‑Time PCR only, no genomic confirmation; 97–98% sensitivity |
| Turnaround Time | 72 hours (Mon‑Thu sample) | 5‑7 working days |
| Price (All‑Inclusive) | 800 AED | 1,200–1,500 AED |
| Home Collection & Cold-Chain | ISO‑certified refrigerated transport, included | Often outsourced; risk of temperature excursions |
🩺 Clinical Insight & Safety Protocol
“As a clinical hematologist, I recognise the anxiety genetic testing can provoke. This assay clarifies your inherited thrombotic risk, enabling tailored prevention. However, a positive result does not independently dictate anticoagulation; it must be correlated with your personal and family history. Please do not stop any prescribed blood‑thinner without a specialist’s guidance.”
— Dr. PRABHAKAR REDDY, DHA License 61713011, Consultant Hematologist
⚠️ Medication Warning
Do not discontinue any prescribed anticoagulant or antiplatelet medication without consulting your doctor. Altering therapy based solely on a genetic report can trigger dangerous clotting events.
Patient Safety Exclusion Criteria & Emergency Red Flags
- Exclusion: Active bleeding, severe thrombocytopenia (platelets <20×10⁹/L), inability to provide informed consent, or known allergy to phlebotomy materials.
- ER Red Flags (post‑test): Sudden severe headache, chest pain, shortness of breath, unilateral limb swelling, or vision changes – these may signal an acute thromboembolic event and require immediate emergency evaluation.
📋 Patient Frequently Asked Questions (FAQ)
1. What is the Prothrombin Gene Mutation (G20210A) test and who should consider it?
Snippet: This genetic analysis detects Factor II G20210A mutation, guiding thrombophilia risk assessment for patients with clotting history.
Candidates include individuals with a first unprovoked VTE before age 50, recurrent thrombosis, or a first‑degree relative carrying the mutation. It is also valuable in pregnancy‑related thrombosis work‑up. A positive result does not necessarily mean you will develop a clot; it identifies a predisposition that, when combined with acquired risks, may warrant prophylaxis.
يكشف هذا التحليل عن طفرة العامل الثاني G20210A لتقييم خطر التجلط الوريدي لدى المرضى الذين لديهم تاريخ تخثر أو تاريخ عائلي. يُنصح به لمن يعانون من تجلط غير مبرر قبل سن الخمسين أو حالات متكررة.
2. How is the test performed and does it require fasting?
Snippet: Home blood collection uses a lavender‑top EDTA tube; no fasting required, but prompt refrigeration is essential.
Our ISO‑certified phlebotomist visits your location (8 AM‑11 PM) and draws a 3 mL whole blood sample into a lavender‑top EDTA tube. The sample is immediately placed in a validated cold‑chain transport (2‑8°C). No fasting is needed, and routine medication (except as discussed with your doctor) does not interfere. Remember: the tube must not be frozen, as that degrades DNA.
يتم جمع عينة الدم في أنبوب EDTA بنفسجي عبر الزيارة المنزلية؛ لا يشترط الصيام ولكن يجب تبريد العينة فوراً وعدم تجميدها للحفاظ على الحمض النووي.
3. How long until I receive my result and what do the outcomes mean?
Snippet: Reports within 72 hours for Monday‑Thursday collections; a positive mutation signals hereditary thrombophilia needing clinical correlation.
Samples collected Monday through Thursday before 11 AM are reported by Wednesday or Saturday, respectively. A heterozygous G20210A mutation increases VTE risk 2‑4 fold; homozygous mutations confer higher risk. Both results require integration with your clinical picture by a hematologist. A negative result does not exclude other thrombophilias (e.g., Factor V Leiden, protein C/S deficiency), so further testing may be advised based on your history.
تصدر النتائج خلال 72 ساعة للعينات المجمعة من الاثنين إلى الخميس؛ والطفرة الإيجابية تشير إلى أهبة التخثر الوراثية وتحتاج إلى تقييم طبي شامل. النتيجة السلبية لا تستبعد اضطرابات تخثر أخرى.
DHA Facility License: 9834453 | ISO 9001:2015 Certification: INT/EGQ/2509DA/3139
Methodology: Real‑Time PCR (qPCR) with Whole Genome Sequencing (WGS) confirmation. Pre‑: Duly filled Genomics Clinical Information Requisition Form (Form 20) mandatory. No sample freezing.
ICD‑10‑CM: D68.52 (Prothrombin gene mutation), D68.69 (Other thrombophilia), Z15.09 (Genetic susceptibility). LOINC: 81618‑5
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians